drugset / Trial / NCT00510406

A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPH

NCT00510406

Phase 2 Completed 919 enrolled Astellas Pharma Inc
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study will examine the efficacy,safety and tolerability of combination therapy of tamsulosin and solifenacin compared to placebo and monotherapy of tamsulosin and solifenacin in the treatment of males with LUTS associated with BPH.

Timeline

Start
2007-01
Primary completion
2007-09
Completion
2007-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Solifenacin Small molecule 3 mg
Comparator Solifenacin Small molecule 6 mg
Comparator Solifenacin Small molecule 9 mg
Comparator Tamsulosin Other / unclassified 0.4 mg Oral